Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

TECH

Bio-Techne Corp

Sep 12 • 04:00PM ET

51.26

-1.95 -3.66 %

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN A BIO QGEN NEO MTD

| Held by: VTI VOO VB RSP VBK SPY IVV XLV IBB IWR

Scroll to Statements

Index	S&P 500	P/E	113.03	EPS (ttm)	0.45	Insider Own	1.16%	Shs Outstand	154.97M	Perf Week	-5.79%
Market Cap	7.97B	Forward P/E	22.69	EPS next Y	2.26	Insider Trans	-1.92%	Shs Float	153.75M	Perf Month	-6.31%
Enterprise Value	8.26B	PEG	9.95	EPS next Q	0.42	Inst Own	103.00%	Short Float	3.33%	Perf Quarter	-0.52%
Income	73.37M	P/S	6.54	EPS this Y	5.15%	Inst Trans	-2.70%	Short Ratio	2.39	Perf Half Y	-14.40%
Sales	1.22B	P/B	4.14	EPS next Y	11.89%	ROA	2.73%	Short Interest	5.12M	Perf YTD	-28.84%
Book/sh	12.38	P/C	49.16	EPS next 5Y	11.36%	ROE	3.68%	52W High	80.95 -36.68%	Perf Year	-30.52%
Cash/sh	1.04	P/FCF	31.08	EPS past 3/5Y	-34.80% -20.58%	ROIC	3.12%	52W Low	46.01 11.41%	Perf 3Y	-38.63%
Dividend Est.	0.25 (0.50%)	EV/EBITDA	21.93	Sales past 3/5Y	3.33% 10.55%	Gross Margin	66.44%	Volatility	4.08% 3.21%	Perf 5Y	-16.72%
Dividend TTM	0.32 (0.62%)	EV/Sales	6.77	EPS Y/Y TTM	-56.70%	Oper. Margin	21.86%	ATR (14)	1.98	Perf 10Y	122.77%
Dividend Ex-Date	Aug 18, 2025	Quick Ratio	2.38	Sales Y/Y TTM	5.23%	Profit Margin	6.02%	RSI (14)	42.09	Recom	1.60
Dividend Gr. 3/5Y	0.00% 0.00%	Current Ratio	3.46	EPS Q/Q	-145.25%	SMA20	-5.40%	Beta	1.48	Target Price	66.23
Payout	69.67%	Debt/Eq	0.23	Sales Q/Q	3.55%	SMA50	-4.88%	Rel Volume	0.92	Prev Close	53.21
Employees	3100	LT Debt/Eq	0.22	Earnings	Aug 06 BMO	SMA200	-13.96%	Avg Volume	2.14M	Price	51.26
IPO	Feb 09, 1989	Option/Short	Yes / Yes	EPS/Sales Surpr.	6.13% 0.75%	Trades		Volume	1,981,714	Change	-3.66%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-03-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$73
Aug-21-25	Upgrade	Citigroup	Neutral → Buy	$70
Jul-22-25	Resumed	Stephens	Overweight	$65
Jul-09-25	Initiated	TD Cowen	Buy	$65
May-30-25	Initiated	Wells Fargo	Overweight	$59
Apr-09-25	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Mar-18-25	Initiated	Evercore ISI	Outperform	$75
Feb-19-25	Downgrade	Robert W. Baird	Outperform → Neutral	$88 → $68
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600

Show Previous Ratings

Sep-10-25 03:11PM	Why Bio-Techne (TECH) Stock Is Down Today (StockStory) -5.98%
Sep-09-25 04:05PM	CONMED Corporation Adds Kim Kelderman to its Board of Directors (Business Wire)
07:00AM	ScaleReady Awards G-Rex Grants to Support Cell and Gene Therapy Manufacturing in California (PR Newswire)
Sep-02-25 02:26PM	Why Bio-Techne (TECH) Shares Are Sliding Today (StockStory)
Aug-27-25 07:00AM	Bio-Techne to Present at Upcoming Investor Conferences (PR Newswire)
03:40PM	Loading…
Aug-22-25 03:40PM	Bio-Techne, 10x Genomics, Lumen, EPAM, and ASGN Shares Are Soaring, What You Need To Know (StockStory) +5.72%
Aug-21-25 09:36AM	CoreWeave upgraded, Instacart downgraded: Wall Street's top analyst calls (The Fly)
Aug-19-25 07:57AM	Bio-Techne Stock: Analyst Estimates & Ratings (Barchart)
Aug-14-25 07:00AM	ScaleReady Announces Award of a G-Rex Grant to the Gates Institute's Translational Sciences Laboratory (PR Newswire)
Aug-13-25 01:35AM	The 5 Most Interesting Analyst Questions From Bio-Techne's Q2 Earnings Call (StockStory)
Aug-12-25 03:17AM	TECH Q2 Deep Dive: Margin Pressures and Portfolio Shifts Amid Market Uncertainty (StockStory) +5.34%
Aug-11-25 02:56PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-06-25 01:20PM	Why Bio-Techne (TECH) Shares Are Plunging Today (StockStory) -8.73%
09:31AM	Bio-Techne (NASDAQ:TECH) Exceeds Q2 Expectations (StockStory)
09:30AM	Here's What Key Metrics Tell Us About Techne (TECH) Q4 Earnings (Zacks)
09:05AM	Loading…
09:05AM	Bio-Techne Q4 Earnings Beat Estimates, Gross Margin Down, Stock Falls (Zacks)
07:50AM	Techne (TECH) Beats Q4 Earnings and Revenue Estimates (Zacks)
06:30AM	Bio-Techne Releases Fourth Quarter Fiscal 2025 Results (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Aug-05-25 04:30PM	Bio-Techne Announces Exosome Diagnostics Divestiture (PR Newswire)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Sidra Medicine (PR Newswire)
Aug-04-25 11:19PM	Earnings To Watch: Bio-Techne (TECH) Reports Q2 Results Tomorrow (StockStory)
09:51AM	Bio-Techne Q4 Earnings Preview: What's in Store for the Stock? (Zacks)
Aug-01-25 08:13AM	Bio-Techne Corporation (TECH) Slid on Weakness in Research Spending (Insider Monkey)
07:46AM	Bio-Techne Corporation (TECH) Slid on Rise in Investors' Concerns (Insider Monkey)
Jul-31-25 07:00AM	ScaleReady announces multiple G-Rex® Grants have been awarded to investigators at University of Minnesota's Center for Genome Engineering (PR Newswire) -5.16%
Jul-30-25 12:03AM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Jul-28-25 02:07AM	Bio-Techne Corporation (TECH) Gets Initiated With a New Buy Rating at TD Cowen (Insider Monkey)
Jul-24-25 04:07PM	Bio-Techne Corporation (TECH): A Bull Case Theory (Insider Monkey) +5.71%
Jul-22-25 02:05PM	Bio-Techne (TECH) Stock Is Up, What You Need To Know (StockStory) +5.67%
01:03AM	Loading…
Jul-18-25 01:03AM	Bio-Technes Quarterly Earnings Preview: What You Need to Know (Barchart)
Jul-17-25 07:00AM	Bio-Techne to Host Conference Call on August 6, 2025, to Announce Fourth Quarter and Fiscal 2025 Financial Results (PR Newswire)
Jul-16-25 11:40AM	INCY or TECH: Which Is the Better Value Stock Right Now? (Zacks)
Jul-15-25 10:09AM	Here's Headwaters Capital Management's Investment Thesis for Bio-Techne (TECH) (Insider Monkey)
09:03AM	Spear Bio Announces Strategic Partnership with Bio-Techne to Accelerate the Deployment of Its Next-Generation Immunoassay Technology (Business Wire)
07:00AM	Bio-Techne and Spear Bio Announce Strategic Partnership to Advance Therapeutic Development with Ultrasensitive Biomarker Detection (PR Newswire)
Jul-14-25 07:00AM	Bio-Techne's Simple Western Technology Utilized in Recent FDA Approval of ZEVASKYN Cell-Based Gene Therapy (PR Newswire)
Jul-09-25 01:33AM	5 Revealing Analyst Questions From Bio-Techne's Q1 Earnings Call (StockStory)
Jun-30-25 08:49AM	Bio-Techne's New USP Deal on mAb and Gene Therapy May Boost Its Stock (Zacks)
Jun-25-25 04:46PM	Bio-Techne, USP Partner to Enhance Monoclonal Antibody, Gene Therapy Development (Insider Monkey)
08:44AM	Is Bio-Techne Stock Underperforming the Nasdaq? (Barchart)
Jun-24-25 07:00AM	Bio-Techne and USP Announce Collaboration to Accelerate Monoclonal Antibody and Gene Therapy Product Development (PR Newswire)
Jun-10-25 01:15PM	TECH Q1 Earnings Call: Management Highlights Market Uncertainties and Strategic Mitigation Efforts (StockStory)
07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Immuneel Therapeutics (PR Newswire)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)
11:31AM	Why Is Techne (TECH) Down 3% Since Last Earnings Report? (Zacks)
Jun-02-25 11:33PM	Spotting Winners: Bio-Techne (NASDAQ:TECH) And Research Tools & Consumables Stocks In Q1 (StockStory)
May-30-25 12:47AM	Bio-Techne Corporation (TECH): A Bull Case Theory (Insider Monkey)
May-29-25 08:47AM	Is Bio-Techne Stock the Right Pick for Your Portfolio Now? (Zacks)
07:00AM	Bio-Techne to Present at Investor Conferences (PR Newswire)
May-14-25 04:54PM	S&P 500 Gains & Losses Today: Supermicro Stock Surges After DataVolt Deal (Investopedia) -7.27%
11:00AM	What Makes Bio-Techne Corporation (TECH) a Compelling Addition? (Insider Monkey)
07:00AM	ScaleReady awards multiple G-Rex Grants to leading investigators at the University of Southern California (USC) and the Children's Hospital of Los Angeles (CHLA) (PR Newswire)
May-12-25 07:00AM	Bio-Techne to Showcase Next-Generation Solutions for Gene and Cell Therapy at American Society of Gene & Cell Therapy 2025 (PR Newswire) +7.93%
May-10-25 11:55AM	Biotech Alert: Searches spiking for these stocks today (TipRanks)
May-08-25 09:30AM	Kytopen and Bio-Techne Collaborate on an Integrated Cellular Engineering Workflow to Expedite Cell Therapy Manufacturing (PR Newswire)
07:00AM	Bio-Techne to Present at the BofA Securities 2025 Health Care Conference (PR Newswire)
03:16AM	Bio-Techne Corp (TECH) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amid Global ... (GuruFocus.com)
01:44AM	Q3 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
May-07-25 04:09PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
10:40AM	Bio-Techne outlines 2025 growth drivers with NIH uncertainty and strong Protein Sciences performance (Seeking Alpha)
10:38AM	Bio-Techne Corporation (TECH) Q3 2025 Earnings Call Transcript (Seeking Alpha)
10:05AM	Bio-Techne Q3 Earnings & Revenues Top Estimates, Stock Up in Premarket (Zacks)
09:54AM	Bio Techne (TECH) Fell on Negative Funding Environment (Insider Monkey)
09:30AM	Techne (TECH) Reports Q3 Earnings: What Key Metrics Have to Say (Zacks)
08:34AM	Is the Options Market Predicting a Spike in BioTechne Stock? (Zacks)
07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
06:30AM	BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2025 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND AND NEW SHARE REPURCHASE PROGRAM (PR Newswire)
May-06-25 07:00AM	ScaleReady awards a $300,000 G-Rex Grant to A2 Biotherapeutics, Inc. (PR Newswire)
May-05-25 10:00AM	Earnings Preview: Arcturus Therapeutics (ARCT) Q1 Earnings Expected to Decline (Zacks)
May-02-25 07:54AM	Should You Hold Bio-Techne Corp. (TECH) For the Long Term? (Insider Monkey)
May-01-25 08:25AM	Alkermes (ALKS) Misses Q1 Earnings and Revenue Estimates (Zacks)
Apr-30-25 10:01AM	Techne (TECH) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
07:51AM	TECH Gears Up to Report Q3 Earnings: Here's What to Expect (Zacks)
Apr-29-25 07:00AM	ScaleReady Announces March Biosciences as Recipient of G-Rex Grant to Advance Manufacturing of Novel CAR-T Cell Therapy (PR Newswire)
Apr-24-25 09:45AM	Aristotle Focus Growth Q1 2025 Commentary (Seeking Alpha)
09:09AM	Bio-Techne Corporation (TECH) Slid Due to NIH's Funding Concerns (Insider Monkey)
07:00AM	Bio-Techne Announces Early Access Program for Next-Generation Spatial Protein Proximity Detection (PR Newswire)
Apr-23-25 07:00AM	Bio-Techne to Showcase Cutting-Edge Solutions at the 2025 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
Apr-21-25 08:00AM	OmniAb Announces Two New Appointments to its Board of Directors (Business Wire)
Apr-15-25 07:00AM	Bio-Techne to Host Conference Call on May 7, 2025, to Announce Third Quarter Fiscal 2025 Financial Results (PR Newswire)
Apr-14-25 02:09PM	Aristotle Large Cap Growth Q1 2025 Commentary (Seeking Alpha)
Apr-11-25 11:20AM	Novavax slides after RFK Jr. casts doubts about COVID vaccine (TipRanks)
Apr-10-25 01:32PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -8.90%
08:40AM	Strength Seen in Bio-Techne (TECH): Can Its 10.8% Jump Turn into More Strength? (Zacks)
Apr-09-25 09:46AM	Apple, Starbucks upgraded: Wall Street's top analyst calls (The Fly) +10.78%
Apr-08-25 06:49PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -6.69%
Apr-03-25 10:03AM	Dianthus Therapeutics, Inc. (DNTH) Soars 6.1%: Is Further Upside Left in the Stock? (Zacks) -6.03%
Apr-02-25 07:00AM	Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument (PR Newswire)
Mar-31-25 10:00AM	Bio-Techne Opens New Customer Experience Centre in Germany (Zacks)
05:12AM	3 Reasons to Avoid TECH and 1 Stock to Buy Instead (StockStory)
Mar-28-25 05:06AM	Research Tools & Consumables Stocks Q4 Earnings: Bio-Techne (NASDAQ:TECH) Best of the Bunch (StockStory)
Mar-26-25 11:10AM	Columbia Acorn Fund Q4 2024 Commentary (SeekingAlpha)
07:00AM	Bio-Techne Announces New Customer Experience Centre in Dsseldorf, Germany (PR Newswire)
Mar-24-25 07:00AM	Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting (PR Newswire)
Mar-17-25 05:09AM	Q4 Rundown: PacBio (NASDAQ:PACB) Vs Other Life Sciences Tools & Services Stocks (StockStory)
Mar-12-25 05:03AM	Q4 Earnings Highlights: Sotera Health Company (NASDAQ:SHC) Vs The Rest Of The Research Tools & Consumables Stocks (StockStory)
05:01AM	Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR) (StockStory)
Mar-10-25 07:00AM	Bio-Techne Begins Shipping Leo - A Next Generation High-Throughput Simple Western System (PR Newswire)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. Its products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Spatial Biology segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Nusse Roeland	Director	Aug 25 '25	Option Exercise	21.84	17,040	372,154	61,599	Aug 27 04:10 PM
Nusse Roeland	Director	Aug 25 '25	Sale	56.36	17,040	960,388	44,559	Aug 27 04:10 PM
BAUMGARTNER ROBERT V	Director	Aug 25 '25	Option Exercise	21.84	17,040	372,154	61,903	Aug 27 04:09 PM
BAUMGARTNER ROBERT V	Director	Aug 25 '25	Sale	56.21	17,040	957,818	44,863	Aug 27 04:09 PM
ROELAND NUSSE	Director	Aug 25 '25	Proposed Sale	56.36	17,040	960,388		Aug 25 04:05 PM
ROBERT V. BAUMGARTNER4731 BONI	Director	Aug 25 '25	Proposed Sale	56.21	17,040	957,849		Aug 25 04:04 PM
Hippel James	CFO	Aug 15 '25	Option Exercise	0.00	4,010	0	131,809	Aug 19 05:38 PM
Herr Amy E.	Director	Aug 15 '25	Option Exercise	0.00	279	0	2,255	Aug 19 05:29 PM
Kelderman Kim	Chief Executive Officer	Aug 15 '25	Option Exercise	0.00	8,543	0	55,273	Aug 19 05:28 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '25	Option Exercise	0.00	1,718	0	4,912	Aug 19 05:28 PM
McManus Matthew	President - Diag & Spatial Bio	Aug 15 '25	Option Exercise	0.00	2,637	0	5,615	Aug 19 05:28 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Aug 15 '25	Option Exercise	0.00	2,623	0	15,915	Aug 19 05:27 PM
HIGGINS JOHN L	Director	Aug 07 '25	Option Exercise	21.84	5,040	110,074	65,236	Aug 11 07:06 PM
Hippel James	CFO	Jul 29 '25	Option Exercise	44.33	168,620	7,474,925	275,230	Jul 31 04:28 PM
Kelderman Kim	Chief Executive Officer	Jul 22 '25	Option Exercise	44.33	48,176	2,135,642	90,379	Jul 24 04:26 PM
Kelderman Kim	Chief Executive Officer	Jul 15 '25	Option Exercise	44.33	36,132	1,601,732	75,136	Jul 17 05:04 PM
Herr Amy E.	Director	Jun 09 '25	Option Exercise	44.33	1,280	56,742	3,256	Jun 11 04:20 PM
Herr Amy E.	Director	Jun 09 '25	Sale	49.77	1,280	63,705	1,976	Jun 11 04:20 PM
JOSHUA MOLHO	Officer	Jun 09 '25	Proposed Sale	49.77	1,280	63,705		Jun 09 04:19 PM
HIGGINS JOHN L	Director	May 01 '25	Option Exercise	21.84	12,000	262,080	60,196	May 05 04:18 PM
Bohnen Shane	SVP - General Counsel	Apr 03 '25	Option Exercise	0.00	2,260	0	3,941	Apr 07 04:25 PM
Herr Amy E.	Director	Feb 14 '25	Option Exercise	44.33	1,976	87,596	3,836	Feb 18 04:49 PM
Herr Amy E.	Director	Feb 14 '25	Sale	65.96	1,860	122,691	1,976	Feb 18 04:49 PM
JOSHUA MOLHO	Domestic Partner of Director	Feb 14 '25	Proposed Sale	65.96	1,860	122,691		Feb 14 04:08 PM
McManus Matthew	President - DGS	Feb 01 '25	Option Exercise	0.00	4,620	0	4,620	Feb 04 05:31 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Feb 01 '25	Option Exercise	0.00	3,320	0	14,401	Feb 04 05:27 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Option Exercise	37.70	13,392	504,878	52,396	Jan 29 04:35 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Sale	77.29	13,392	1,035,013	39,004	Jan 29 04:35 PM
KIM KELDERMAN	Director	Jan 27 '25	Proposed Sale	77.05	13,392	1,031,854		Jan 27 04:24 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 01 '24	Option Exercise	0.00	9,912	0	14,351	Nov 05 04:48 PM
Hippel James	CFO	Nov 01 '24	Option Exercise	0.00	13,159	0	113,085	Nov 05 04:46 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience